Recombinant HLA-DRA antibody

Catalog No. ABIN7826065

This Mouse Monoclonal antibody specifically detects HLA-DRA in FACS and ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant HLA-DRA antibody (ABIN7826065)

Target: HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This HLA-DRA antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA

Grade: In vivo Grade

Clone: L243

Product Details anti-HLA-DRA Antibody

Expression System: CHO Cells

Purpose: HLA-DR recombinant monoclonal antibody, clone L243 targeting human HLA-DR recombinant protein.

Cross-Reactivity: Human

Characteristics: In Vivo Functional Grade Antibodies are optimized for mouse and rat studies, ensuring safety and accuracy in live animal experiments. Each antibody is highly purified and validated by flow cytometry using positive and negative control cell lines. The collection includes mouse-target and human-target antibodies suitable for syngeneic and xenograft tumor models, supporting robust preclinical immunotherapy research

Purification: Protein A purified

Purity: > 95 % by SDS-PAGE under reducing conditions.

Sterility: 0.2 μm filtered

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method.

Immunogen: Human HLA-DR recombinant protein

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: ≥ 3 μg/μL

Buffer: PBS pH 7.4 with no stabilizers or preservatives added

Preservative: Without preservative

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot to avoid repeated freezing and thawing.

Expiry Date: 12 months

Target Details for HLA-DRA

Target: HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Alternative Name: HLA-DRA

Background:

Gene description: major histocompatibility complex, class II, DR alpha

Gene alias: HLA-DRA1

Gene ID: 3122

Pathways: TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response